| Authors: |
Lincoff AM; Department of Cardiovascular Medicine and Cleveland Clinic Coordinating Center for Clinical Research (C5Research), Cleveland Clinic, Cleveland, Ohio, USA. Electronic address: lincofa@ccf.org., Ray KK; Imperial College London, London United Kingdom., Sasiela WJ; Esperion Therapeutics, Inc, Ann Arbor Michigan, USA., Haddad T; Virginia Heart, Falls Church, Virginia, USA., Nicholls SJ; Victorian Heart Institute, Monash University, Melbourne, Victoria, Australia., Li N; Esperion Therapeutics, Inc, Ann Arbor Michigan, USA., Cho L; Department of Cardiovascular Medicine and Cleveland Clinic Coordinating Center for Clinical Research (C5Research), Cleveland Clinic, Cleveland, Ohio, USA., Mason D; Department of Cardiovascular Medicine and Cleveland Clinic Coordinating Center for Clinical Research (C5Research), Cleveland Clinic, Cleveland, Ohio, USA., Libby P; Brigham and Women's Hospital, Boston, Massachusetts, USA., Goodman SG; St. Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada., Nissen SE; Department of Cardiovascular Medicine and Cleveland Clinic Coordinating Center for Clinical Research (C5Research), Cleveland Clinic, Cleveland, Ohio, USA. |